|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
AVI Biopharma Axes 28% of Workforce, After Missing Out on Flu Contract
|
Luke Timmerman |
12/12/11 |
Seattle
|
|
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company
|
Luke Timmerman |
06/02/11 |
Seattle
|
|
Tekmira and AVI Win Ebola Deals, Mirador’s Idea to Prevent Hospital Errors, Tom Ranken’s New Mission, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/22/10 |
Seattle
|
|
AVI Biopharma Wins Big Ebola Contract Worth up to $291M
|
Luke Timmerman |
07/16/10 |
Seattle
|
|
Tekmira Nails $140M Defense Contract to Make RNAi Drug for Ebola
|
Luke Timmerman |
07/15/10 |
Seattle
|
|
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/22/10 |
Seattle
|
|
AVI Biopharma Eagerly Awaits Data on Muscular Dystrophy Drug
|
Luke Timmerman |
02/01/10 |
Seattle
|
|
AVI Nabs $11.5M Defense Contract
|
Luke Timmerman |
10/05/09 |
Seattle
|
|
AVI Biopharma Settles Into New Digs, Scopes Out Seattle Biotech Talent Pool
|
Luke Timmerman |
09/29/09 |
Seattle
|
|
AVI Nails Down $30M
|
Luke Timmerman |
08/20/09 |
Seattle
|
|
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/06/09 |
Seattle
|
|
AVI Biopharma Bolts from Portland to Seattle to Tap Biotech Talent
|
Luke Timmerman |
07/30/09 |
Seattle
|
|
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/07/09 |
Seattle
|
|
Dendreon Drug Prolongs Life, ZymoGenetics Cuts Staff, Microsoft Tackles Biotech & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/30/09 |
Seattle
|
|
Ebola Fighter AVI Biopharma Gears Up for Biodefense Contracts
|
Luke Timmerman |
04/29/09 |
Seattle
|
|
AVI Gets Patent For Ebola Drug
|
Luke Timmerman |
04/28/09 |
Seattle
|
|
Pathway Medical Gets Traction, Ekos Raises $12.5M, ZymoGenetics Sales Boss Departs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
02/05/09 |
Seattle
|
|
AVI Gets Green Light for Ebola Trial
|
Luke Timmerman |
12/24/08 |
Seattle
|
|
AVI Biopharma Out to Reinvent Itself, Making RNA-based Drugs for Ebola and Other Nasty Things
|
Luke Timmerman |
09/10/08 |
Seattle
|
|
Spaltudaq Harnessing Mother Nature’s Wisdom to Make Better Drugs For Infections
|
Luke Timmerman |
08/28/08 |
Seattle
|
|
Alnylam’s Ebola Work Gets $7.5 Million Commitment
|
Luke Timmerman |
08/06/08 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
